Evommune Inc (EVMN) Price Prediction & Forecast

$13.230

-0.245 (-1.85%)At close

Price Predictions

1-Day Price Prediction

+0.60%

1-Week Prediction

+1.52%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

EVMN Prediction & Forecast by Similar Chart Analysis

Alphio's EVMN stock price prediction model matches the current Evommune Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.31 (+0.60%). The 1-week path is $13.43 (+1.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Evommune Inc Stock?

Evommune, Inc. is currently trading at $13.23, significantly below analyst price targets of $28 and $29, indicating potential upside of over 110%. However, the stock is under pressure due to disappointing trial results, with a recent 31% drop after a failed Phase 2b trial. The RSI is at 37.82, suggesting the stock is not yet in a strong buying position. Given these factors, while there is potential for recovery, the risks associated with its recent performance and ongoing trials warrant a hold recommendation for now.